SCHEMBL845375

SCHEMBL845375

COc1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccnc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.46
ALDH1A1 P00352 3/20 0.45
ROCK2 O75116 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
GFER P55789 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 1/20 0.42
APP P05067 2/20 0.41
GAA P10253 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845015 0.89 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL845284 0.86 MAPK1 (0.58) MAPK1ALDH1A1ROCK2MEN1KMT2A
SCHEMBL845376 0.85 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL845401 0.85 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL845191 0.84 HRH3 (0.52) ALDH1A1ROCK2KDM4E
SCHEMBL845712 0.84 HRH3 (0.50) ALDH1A1KDM4E
SCHEMBL845534 0.84 HRH3 (0.43) ALDH1A1KMT2AKDM4EATM
SCHEMBL845643 0.81 MAPK1 (0.50) MAPK1ALDH1A1ROCK2KMT2ACYP2C9
SCHEMBL845279 0.81 ALDH1A1 (0.53) MAPK1ALDH1A1MEN1KMT2ACYP2C9
SCHEMBL845618 0.80 MAPK1 (0.56) MAPK1ALDH1A1MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed